Loss of sterility or dosing accuracy potency declines often without visible change (colour change or cloudiness may be late indicators)
By pairing a GHRH analogue (Tesamorelin) with a selective GH secretagogue (Ipamorelin), this formulation provides a synergistic approach to elevating endogenous growth hormone levels, promoting lean body composition, reducing visceral adipose tissue, and supporting recovery
For patients with diabetes, we use an IV bag with a non-dextrose base instead of our Hydration formula to prevent elevation in your blood sugar with your treatment
This safety profile stands in contrast to the concerns surrounding some other research peptides, where regulatory questions and limited human data create uncertainty
For example, endocrine experts caution that the age-related GH decline might even be protective (theres ongoing debate), and artificially raising hormone levels in someone without deficiency could do more harm than good